Blackstone Inc’s Boundless Bio BOLD Stock Holding History

Blackstone Inc’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$428K	–	201
2024 Q1	$428K	Buy	+30,000	New	+$428K	﹤0.01%	156

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Blackstone Inc's BOLD Position: Q2 2024 in Review

Blackstone Inc sold out of Boundless Bio (BOLD) in Q2 2024, closing a stake of 30,000 shares — an estimated $428K sold.

Blackstone Inc first reported a position in BOLD in Q1 2024 and held it in 1 quarter. The position peaked at $428K in Q1 2024. 47 funds tracked by Wall St. Rank hold BOLD as of Q2 2024.

Blackstone Inc reported no remaining Boundless Bio position as of Q2 2024 after selling out during the quarter.
Blackstone Inc sold 30,000 Boundless Bio shares in Q2 2024, an estimated $428K.
Blackstone Inc first reported a position in Boundless Bio in Q1 2024 and held it in 1 quarter.
Blackstone Inc's Boundless Bio position peaked at $428K in Q1 2024.
47 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2024.

Based on Blackstone Inc's 13F filing for Q2 2024, filed 14 Aug 2024.